Blueprint Bio nearly raised $100m as biosecurity community debates slow returns on biotech
tyler_m_john · x · 2026-09-06
In a debate over biosecurity strategy, davidmanheim argues technical interventions like Blueprint Bio show real progress but have long RoI horizons — the fund backed David Baker's work in 2018, much of which is still in early-stage clinical trials. tylermjohn says he loves Blueprint Bio and nearly helped it raise $100m last year, adding that no one expected AI to move this fast, strengthening his case for top operators and doing everything faster.
More from AGI Musings
- Edison didn't invent electricity — he invented the electric bill, argues thread — acmoytoy · 2026-09-06
- 20 Accounts Worth Following to Rebuild Your AI Feed From Scratch — yawnxyz · 2026-09-06
- Electrical engineering may be the next profession AI disrupts sooner than expected — Christs_Elite · 2026-09-06
- Jensen Huang slams doom talk as AI safety field shifts from doomer narratives to practical risks — sudoraohacker · 2026-09-06
- a16z GP: the 'permanent underclass' is fantasy, AI job-loss hasn't played out — lennysan · 2026-09-06
- AI Ends Studio Monopoly on Filmmaking: Taste and Storytelling Become the Edge — TansuYegen · 2026-09-06